Rapid Therapeutic Science Laboratories, Inc. (RTSL)
OTCMKTS
· Delayed Price · Currency is USD
0.0016
0.00 (0.00%)
At close: Dec 24, 2024
RTSL Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
30.38K
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Rapid Therapeutic Science Laboratories News
- 1 year ago - White House Office of Management and Budget review on Cannabis-Derived Products confirms Rapid Therapeutic Science Laboratories' Long-Term Strategy - GlobeNewsWire
- 2 years ago - Rapid Therapeutic Science Laboratories Updates Patents - GlobeNewsWire
- 2 years ago - Rapid Therapeutic Science Laboratories File S1 and completes Mid-Year Strategy Review - GlobeNewsWire
- 3 years ago - Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference - GlobeNewsWire
- 3 years ago - Rapid Therapeutic Science Laboratories Secures Upgraded Laboratory and Manufacturing Facility - GlobeNewsWire